Currently viewing the category: "Lipitor"

Splitting pills slashes drug costs

By · 2 Comments

MSN has a helpful article on saving money on your prescription medications by splitting pills:

In pill splitting, patients cut larger-dose tablets in half to double the amount of smaller-dose pills they receive in a single prescription — for example, dividing 40-milligram tablets to create twice as many 20-milligram doses for the same [...]

Continue Reading →

Lipitor approved for new uses

By · 1 Comment

Pfizer has received approval to sell the cholesterol-lowering drug Lipitor, its number-one seller, under five new categories. According to reports, Lipitor

is now recommended for use in patients at high risk for cardiovascular conditions because of prior MI, heart surgery, or chest pain with evidence of atherosclerosis and to reduce the risk [...]

Continue Reading →

It’s dangerous that so many Americans can’t afford prescription drugs

By · 1 Comment

A study published in a special issue of The American Journal of Managed Care has found that the higher a consumer’s out-of-pocket prescription drug expenses, the less likely the consumer is to take needed medications — in particular, cholesterol-lowering medications such as Lipitor and Zocor.

According to the news release from Thomson Medstat:

[...]

Continue Reading →

Do Big Pharma TV ads make you sick?

By · Leave a Comment

Bob Hill of the Louisville Courier-Journal describes New Year’s Day in front of his television set:

Here comes Dr. Robert Jarvik … selling Lipitor to lower your cholesterol. The guy looks good. I’m with him all the way, even through the disclaimer part that suggests Lipitor should not be used if you have [...]

Continue Reading →

Generics will soon be nipping at Lipitor’s heels

By · Leave a Comment

From Reuters:

Pfizer Inc. is bracing for cheap competition to its biggest-selling product, the cholesterol drug Lipitor, a further worry for investors already reeling from the failure of its most important experimental medication. Last week, a raft of generic drugmakers announced that they had received U.S. approval to sell cheap versions of Merck [...]

Continue Reading →